Extrastriatal dopamine D(2) receptor binding in Huntington's disease (Q45299934)

11 December 2017

title

Extrastriatal dopamine D(2) receptor binding in Huntington's disease (English)

1 reference

11 December 2017

0 references

Christer Halldin

1 reference

11 December 2017

Lars Farde

1 reference

11 December 2017

Mouna Esmaeilzadeh

1 reference

11 December 2017

Per Karlsson

1 reference

11 December 2017

Andrea Varrone

1 reference

11 December 2017

Susanna Waters

1 reference

11 December 2017

Joakim Tedroff

1 reference

11 December 2017

publication date

30 September 2010

1 reference

11 December 2017

0 references

1 reference

11 December 2017

1 reference

11 December 2017

1 reference

11 December 2017

page(s)

1626-1636

1 reference

Frontal and temporal dopamine release during working memory and attention tasks in healthy humans: a positron emission tomography study using the high-affinity dopamine D2 receptor ligand [11C]FLB 457.

11 December 2017

cites work

1 reference

An overview of psychiatric symptoms in Huntington's disease

21 January 2018

1 reference

Huntington's disease progression. PET and clinical observations.

21 January 2018

1 reference

Dopamine determines the vulnerability of striatal neurons to the N-terminal fragment of mutant huntingtin through the regulation of mitochondrial complex II.

21 January 2018

1 reference

Pharmacological management of Huntington's disease: an evidence-based review

21 January 2018

1 reference

D2 receptors in Huntington's disease: positron emission tomography findings and clinical correlates

21 January 2018

1 reference

Measuring dopamine neuromodulation in the thalamus: using [F-18]fallypride PET to study dopamine release during a spatial attention task

21 January 2018

1 reference

Early changes in Huntington's disease patient brains involve alterations in cytoskeletal and synaptic elements

21 January 2018

1 reference

A PET-study of [ 11 C]FLB 457 binding to extrastriatal D 2 -dopamine receptors in healthy subjects and antipsychotic drug-treated patients

21 January 2018

1 reference

Stereoselective binding of 11C-raclopride in living human brain--a search for extrastriatal central D2-dopamine receptors by PET.

21 January 2018

1 reference

Thalamic metabolism and symptom onset in preclinical Huntington's disease

21 January 2018

1 reference

Thalamic volumes in patients with first-episode schizophrenia

21 January 2018

1 reference

PET study of the pre- and post-synaptic dopaminergic markers for the neurodegenerative process in Huntington's disease

21 January 2018

1 reference

Identification of extrastriatal dopamine D2 receptors in post mortem human brain with [125I]epidepride

21 January 2018

1 reference

Simplified reference tissue model for PET receptor studies.

21 January 2018

1 reference

Carbon-11 epidepride: a suitable radioligand for PET investigation of striatal and extrastriatal dopamine D2 receptors

21 January 2018

1 reference

The relationship between striatal dopamine receptor binding and cognitive performance in Huntington's disease

21 January 2018

1 reference

The platelet maximum number of A2A-receptor binding sites (Bmax) linearly correlates with age at onset and CAG repeat expansion in Huntington's disease patients with predominant chorea.

21 January 2018

1 reference

A quantitative model for the in vivo assessment of drug binding sites with positron emission tomography

21 January 2018

1 reference

PACSIN 1 interacts with huntingtin and is absent from synaptic varicosities in presymptomatic Huntington's disease brains

21 January 2018

1 reference

Effect of endogenous dopamine on extrastriatal [¹¹C]FLB 457 binding measured by PET.

21 January 2018

1 reference

Potentials and pitfalls using high affinity radioligands in PET and SPET determinations on regional drug induced D2 receptor occupancy--a simulation study based on experimental data

21 January 2018

1 reference

Progressive striatal and cortical dopamine receptor dysfunction in Huntington's disease: a PET study.

21 January 2018

1 reference

Cortical dopamine dysfunction in symptomatic and premanifest Huntington's disease gene carriers

21 January 2018

1 reference

Hypothalamic involvement in Huntington's disease: an in vivo PET study

21 January 2018

1 reference

Functional brain changes in presymptomatic Huntington's disease

21 January 2018

1 reference

Alterations in dopaminergic receptors in Huntington's disease

21 January 2018

1 reference

Brain atlases--a new research tool

21 January 2018

1 reference

Endogenous competition against binding of [(18)F]DMFP and [(18)F]fallypride to dopamine D(2/3) receptors in brain of living mouse

21 January 2018

1 reference

Regional cortical thinning in preclinical Huntington disease and its relationship to cognition

21 January 2018

1 reference

Cerebral cortex and the clinical expression of Huntington's disease: complexity and heterogeneity

21 January 2018

1 reference

Widespread expression of the human and rat Huntington's disease gene in brain and nonneural tissues

21 January 2018

1 reference

Extrastriatal dopamine D2 receptor density and affinity in the human brain measured by 3D PET.

21 January 2018

1 reference

Homozygosity for CAG mutation in Huntington disease is associated with a more severe clinical course

21 January 2018

1 reference

Dopaminergic signaling and striatal neurodegeneration in Huntington's disease

21 January 2018

1 reference

Changes in striatal dopamine D2 receptor binding in pre-clinical Huntington's disease

21 January 2018

1 reference

Hypokinesia in Huntington's disease

21 January 2018

1 reference

Advancement in PET quantification using 3D-OP-OSEM point spread function reconstruction with the HRRT.

21 January 2018

1 reference

Striatal D1 and D2 dopamine receptor loss in asymptomatic mutation carriers of Huntington's disease

21 January 2018

1 reference

PET scan investigations of Huntington's disease: cerebral metabolic correlates of neurological features and functional decline

21 January 2018

1 reference

Unified Huntington's disease rating scale: Reliability and consistency

21 January 2018

1 reference

Correction of PET data for partial volume effects in human cerebral cortex by MR imaging.

21 January 2018

1 reference

12 December 2020

Carbon-11-FLB 457: a radioligand for extrastriatal D2 dopamine receptors

1 reference

12 December 2020

Variability in D2-dopamine receptor density and affinity: a PET study with [11C]raclopride in man

1 reference

12 December 2020

Association between decline in brain dopamine activity with age and cognitive and motor impairment in healthy individuals

1 reference

12 December 2020

1 reference

12 December 2020

Head fixation device for reproducible position alignment in transmission CT and positron emission tomography

1 reference

12 December 2020

1 reference

12 December 2020

Autoradiographic localization of extrastriatal D2-dopamine receptors in the human brain using [125I]epidepride

1 reference

12 December 2020

Identifiers

DOI

10.1002/HBM.21134

1 reference

11 December 2017

0 references

1 reference